4.3 Article

Hydroxyapatite/mesoporous silica coated gold nanorods with improved degradability as a multi-responsive drug delivery platform

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.msec.2017.11.012

Keywords

Gore-shell nanoparticles; Gold nanorods; Hybrid silica/hydroxyapatite; Degradation; NIR-/pH-responsiveness; Drug delivery

Funding

  1. Henan Provincial Natural Science Foundation of China [162300410257]
  2. National Natural Science Foundation of China [20874090]

Ask authors/readers for more resources

In this study, gold nanorods/mesoporous silicaAydroxyapatite (Au/SiO2/HAP) hybrid nanoparticles with AuNR core and SiO2/HAP hybrid inorganic shell for multi-responsive drug delivery had been prepared. The morphology and structure of the nanoparticles were characterized by TEM, XPS, XRD, FT-IR and N-2 adsorption-desorption isotherms. The degradation of the hybrid nanoparticles could be significantiy improved by the dissolution of HAP from the hybrid skeleton in acid environment. In vitro drug release results indicated that Au/SiO2/HAP nanoparticles exhibited high drug loading efficiency, excellent near-infrared (NIR)-and ptfcre-sponsive drug release properties. Compared to the drug release of Au/SiO2 nanoparticles over 12 h (about 6.35%), AU/SiO2/HAP nanoparticles displayed a higher drug release of 37.62% upon NIR irradiation at pH 4.5 due to the NIR-responsiveness of AuNRs and the pH-responsiveness of HAP in acid media. The cell viability results also indicated that the Au/SiO2/HAP nanoparticles exhibited the excellent biocompatibility. The present paper provides a facile route to fabricate a hybrid drug carrier with high drug loading efficiency, excellent pH sensitivity, NIR-sensitivity, biodegradability and biocompatibility.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available